# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $13 to $12.
TrueBlue (NYSE:TBI) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.05) by 60...
BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and maintains $13 price target.
BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $15 to $13.
Baird analyst Mark Marcon maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $14 to $13.
-SEC Filing
TrueBlue (NYSE:TBI) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.37) by 108....